Gas-propelled microneedles for precision transdermal therapeutics.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 42733543.
- Also identified by DOI 10.1016/j.bioactmat.2026.08.059 and PMC identifier 13571514.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Transdermal drug delivery is an appealing approach because it is easy to administer, bypasses first-pass metabolism, and utilizes an extensive surface area of the skin. Microneedles, as an emerging transdermal drug delivery system, offer minimal invasiveness, painlessness, and targeted <i>in</i>-<i>situ</i> treatment. However, the existing microneedle technologies rely on passive diffusion, which can result in unpredictable drug penetration profiles. To enhance the active deep penetration and diffusion of cargoes of the microneedles, gas-propelled microneedles have gradually gained attention from researchers. Gas components can improve transdermal drug delivery efficiency by enhancing drug penetration via pressure effects and bubble generation. Meanwhile, therapeutic gases themselves may function as bioactive components, providing synergistic therapeutic benefits in addition to drug delivery. Hence, Gas-propelled microneedles are promising drug delivery platforms. This review first introduces the structure of the skin and the mechanisms underlying transdermal permeation, followed by a comprehensive overview of recent advances in gas-propelled microneedles for enhancing transdermal drug delivery. We outlined the optimal application strategies based on the distinct properties of different gas-propelled microneedles. It also underscored optimal design strategies for gas-propelled microneedles, assisting formulators in making well-informed decisions. Ultimately, we discussed the current shortcomings of gas-propelled microneedles and future development directions.